Literature DB >> 22107848

Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer.

Daming Zhu1, Shuhui Huang, Holly McClellan, Weili Dai, Najam R Syed, Elizabeth Gebregeorgis, Kelly M Rausch, Gregory E D Mullen, Carole Long, Laura B Martin, David Narum, Patrick Duffy, Louis H Miller, Allan Saul.   

Abstract

Efficient antigen extraction from vaccines formulated on aluminum hydroxide gels is a critical step for the evaluation of the quality of vaccines following formulation. It has been shown in our laboratory that the efficiency of antigen extraction from vaccines formulated on Alhydrogel decreased significantly with increased storage time. To increase antigen extraction efficiency, the present study determined the effect of surfactants on antigen recovery from vaccine formulations. The Plasmodium falciparum apical membrane antigen 1 (AMA1) formulated on Alhydrogel and stored at 2-8°C for 3 years was used as a model in this study. The AMA1 on Alhydrogel was extracted in the presence or absence of 30 mM sodium dodecyl sulfate (SDS) or 20mM cetylpyridinium chloride in the extraction buffer (0.60 M citrate, 0.55 M phosphate, pH 8.5) using our standard antigen extraction protocols. Extracted AMA1 antigen was analyzed by 4-20% Tris-glycine SDS-PAGE followed by silver staining or western blotting. The results showed that inclusion of SDS or cetylpyridinium chloride in extraction buffer increased the antigen recovery dramatically and can be used for efficient characterization of Alhydrogel vaccines. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22107848      PMCID: PMC3246088          DOI: 10.1016/j.vaccine.2011.11.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

1.  Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits.

Authors:  M Chang; Y Shi; S L Nail; H HogenEsch; S B Adams; J L White; S L Hem
Journal:  Vaccine       Date:  2001-04-06       Impact factor: 3.641

2.  Aluminum compounds as vaccine adjuvants.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-07-06       Impact factor: 15.470

3.  Predicting the adsorption of proteins by aluminium-containing adjuvants.

Authors:  S J Seeber; J L White; S L Hem
Journal:  Vaccine       Date:  1991-03       Impact factor: 3.641

4.  Effect of pH on the Elution of Model Antigens from Aluminum-Containing Adjuvants.

Authors: 
Journal:  J Colloid Interface Sci       Date:  1998-09-01       Impact factor: 8.128

5.  Role of the electrostatic attractive force in the adsorption of proteins by aluminum hydroxide adjuvant.

Authors:  M F Chang; J L White; S L Nail; S L Hem
Journal:  PDA J Pharm Sci Technol       Date:  1997 Jan-Feb

6.  Long term stability of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Montanide(®) ISA 720 and stabilized with glycine.

Authors:  Daming Zhu; Holly McClellan; Weili Dai; Elizabeth Gebregeorgis; Mary Anne Kidwell; Joan Aebig; Kelly M Rausch; Laura B Martin; Ruth D Ellis; Louis Miller; Yimin Wu
Journal:  Vaccine       Date:  2011-04-08       Impact factor: 3.641

7.  Treatment of aluminium hydroxide adjuvant to optimize the adsorption of basic proteins.

Authors:  J V Rinella; J L White; S L Hem
Journal:  Vaccine       Date:  1996-03       Impact factor: 3.641

8.  Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins.

Authors:  Seema Iyer; Harm HogenEsch; Stanley L Hem
Journal:  Pharm Dev Technol       Date:  2003       Impact factor: 3.133

9.  Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants.

Authors:  R H al-Shakhshir; F E Regnier; J L White; S L Hem
Journal:  Vaccine       Date:  1995-01       Impact factor: 3.641

10.  Changes in the SDS elutability of fibrinogen adsorbed from plasma to polymers.

Authors:  R J Rapoza; T A Horbett
Journal:  J Biomater Sci Polym Ed       Date:  1989       Impact factor: 3.517

View more
  4 in total

1.  Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresis.

Authors:  Virginie Jakob; Livia Brunner; Christophe Barnier-Quer; Molly Blust; Nicolas Collin; Lauren Carter; Darrick Carter; Kelly M Rausch; Christopher B Fox
Journal:  Ther Adv Vaccines       Date:  2017-05-03

2.  Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide.

Authors:  Carly Fleagle Chisholm; Taek Jin Kang; Miao Dong; Kasey Lewis; Madhuri Namekar; Axel T Lehrer; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2019-01-28       Impact factor: 5.571

3.  VaxArray immunoassay for the multiplexed quantification of poliovirus D-antigen.

Authors:  Erica D Dawson; Amber W Taylor; James E Johnson; Tianjing Hu; Caitlin McCormick; Keely N Thomas; Rachel Y Gao; Rahnuma Wahid; Kutub Mahmood; Kathy L Rowlen
Journal:  J Immunol Methods       Date:  2022-03-18       Impact factor: 2.287

4.  Characterization of the UK anthrax vaccine and human immunogenicity.

Authors:  Tapasvi Modi; David Gervais; Stuart Smith; Julie Miller; Shaan Subramaniam; Konstantinos Thalassinos; Adrian Shepherd
Journal:  Hum Vaccin Immunother       Date:  2020-09-08       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.